https://www.selleckchem.com/pr....oducts/bso-l-buthion
001) and the myocardial blush grade (p .001) were significantly lower in CAE than in no CAE patients. The mean follow-up was 1,218.3 ± 574.8 days. The adjusted risk for the primary outcome resulted significantly higher in patients with CAE compared to those without (adjusted HR 1.84; p = .017). No differences in terms of all-cause and cardiac death were found between groups. In this study, STEMI patients with CAE had a distinct clinical and angiographic profile, and showed a significantly higher risk of rec
Like
Comment
Share
